1. Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study. Issue 11 (November 2019) Authors: Herling, Carmen D; Coombes, Kevin R; Benner, Axel; Bloehdorn, Johannes; Barron, Lynn L; Abrams, Zachary B; Majewski, Tadeusz; Bondaruk, Jolanta E; Bahlo, Jasmin; Fischer, Kirsten; Hallek, Michael; Stilgenbauer, Stephan; Czerniak, Bogdan A; Oakes, Christopher C; Ferrajoli, Alessandra; Keating, Mic... Journal: Lancet oncology Issue: Volume 20:Issue 11(2019) Page Start: 1576 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Unsupervised machine learning and prognostic factors of survival in chronic lymphocytic leukemia. (1st June 2020) Authors: Coombes, Caitlin E; Abrams, Zachary B; Li, Suli; Abruzzo, Lynne V; Coombes, Kevin R Journal: Journal of the American Medical Informatics Association Issue: Volume 27:Number 7(2020) Page Start: 1019 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗